1233497-37-4

Basic information

• Product Name: (E)-tert-butyl 4-((2-(3-oxo-3-(4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenylsulfonamido)propyl)phenyl)diazenyl)benzoate
• Synonyms: (E)-tert-butyl 4-((2-(3-oxo-3-(4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenylsulfonamido)propyl)phenyl)diazenyl)benzoate
• CAS NO: 1233497-37-4
• Molecular Weight: 717.769
• Mol File: 1233497-37-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (E)-tert-butyl 4-((2-(3-oxo-3-(4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenylsulfonamido)propyl)phenyl)diazenyl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-tert-butyl 4-((2-(3-oxo-3-(4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenylsulfonamido)propyl)phenyl)diazenyl)benzoate(1233497-37-4)
• EPA Substance Registry System: (E)-tert-butyl 4-((2-(3-oxo-3-(4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenylsulfonamido)propyl)phenyl)diazenyl)benzoate(1233497-37-4)

Safety Data

• Hazardous Substances Data: 1233497-37-4(Hazardous Substances Data)

Upstream product

• 1233497-42-1 C₂₀H₂₂N₂O₄ 
• 169590-42-5 4-[5-(4-(methyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulphonamide 

Relevant articles and documents

TARGETING PRODRUGS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES

Provided herein are compounds, compositions and methods for preventing or treating gastrointestinal cancer in a mammal, wherein the method comprises delivering an effective amount of a COX-2 or a similar sulfonamide inhibitor as a prodrug or derivative thereof to the colon, wherein the COX-2 or similar inhibitor is released in- vivo.